Six Institutions Receive the IDSA Antimicrobial Stewardship Center of Excellence Designation

IDSA calls on Congress to pass the PASTEUR Act to help address antimicrobial resistance.

Medicare Physician Fee Schedule Is a Serious Setback to a Robust Infectious Diseases Workforce

These experts safeguard America’s health, including helping the nation recover from COVID-19, address RSV, and prevent polio, flu and monkeypox, among other conditions.

Upstream Intervention Effective in Reducing Unnecessary Antibiotic Prescriptions

Diagnostic stewardship is more effective than antibiotic stewardship at reducing unnecessary antibiotic use for patients treated for urinary tract infections who have asymptomatic bacteriuria, according to research presented at IDWeek.

HIV Care Interventions Crucial to Reducing Life Expectancy Disparities Between White and Black MSM with HIV

The life expectancy  of non-Hispanic Black men who have sex with men  and who acquire HIV is 6.3 years shorter than their White counterparts when receiving status quo HIV care in the United States, according to simulation modeling findings presented at IDWeek.

Study Shows Moderna’s Omicron Bivalent Booster Vaccine Is Safe And Induces Higher Antibody Responses Than Original COVID-19 Vaccine

A bivalent mRNA booster vaccine targeting the Omicron BA.1 variant of COVID-19 produces a significantly higher antibody response compared to the original vaccine with no new safety concerns, according to research presented at IDWeek.

Chickenpox Now Rare In U.S. Due To Routine Vaccination

Chickenpox cases have decreased 97% since the United States began vaccinating all children against the disease in 1995, according to research presented at IDWeek.

IDWeek Research: COVID-19 Is Associated With Reported Long-Term Effects on U.S. Military Members’ Physical Fitness

COVID-19 is associated with reported long-term effects on the physical fitness of U.S. military members.

IDSA Honors Notable Leaders in Infectious Diseases at IDWeek 2022

The Infectious Diseases Society of America is honoring 12 of its members who are leaders in the field at IDWeek 2022. IDSA recognizes the following for excellence in the field of infectious diseases.

Carlos del Rio, MD, FIDSA, Named IDSA President

The Infectious Diseases Society of America is pleased to announce Carlos del Rio, MD, FIDSA, as the Society’s new president beginning Oct. 24.

Infectious Diseases Experts: “Don’t Wait to Be Boosted”

IDSA urges everyone who is eligible to get boosted now as COVID-19 cases increase in Europe and other parts of the world — a sign that a surge could happen in the United States.

IDSA Statement on Global Fund Replenishment

IDSA and HIVMA are pleased that global efforts to end the HIV, tuberculosis and malaria epidemics received much needed investment at the seventh replenishment of the Global Fund to Fight AIDS, Tuberculosis and Malaria.

IDSA to the Public: Get Your COVID-19 Boosters

Tremendous progress has been made in controlling the spread of COVID-19 and curbing its most lethal effects. There are now multiple types of vaccines, therapeutic options and a new vaccine that targets the prevailing, more contagious strain of COVID-19.